Characterization of on-target adverse events caused by TRK inhibitor therapy
D. Liu, James Flory, Andrew Lin, Michael Offin, Christina J. Falcon, Yonina R. Murciano‐Goroff, Ezra Y. Rosen, Robin Guo, Ellen M. Basu, Bob T. Li, James J. Harding, Gopa Iyer, Komal Jhaveri, Mrinal M. Gounder, Neerav Shukla, Stephen S. Roberts, Julia Glade Bender, Lauren A. Kaplanis, Alison M. Schram, David M. Hyman, Alexander Drilon
Topics & Concepts
MedicineTrk receptorAdverse effectOncologyInternal medicineNeurotrophinReceptorMelanoma and MAPK PathwaysPain Mechanisms and TreatmentsIon Channels and Receptors